LifeCell Corporation was formed in 1986 to market a unique tissue preservation technology. Today, LifeCell develops and markets innovative tissue repair products for the reconstructive, orthopedic and urogynecologic biosurgery markets. The company’s mission is to transform surgery through continuous innovation. By leveraging our scientific heritage and proprietary technologies, we will passionately commit ourselves to exceed customer expectations, raise industry standards, and improve patients' lives.
AlloDerm® Regenerative Tissue Matrix, the flagship of LifeCell, was developed in 1994 as a graft for burn patients. Since that time, the remarkable versatility or AlloDerm® Tissue Matrix has led to its use in a host of other reconstructive applications, primarily in hernia, abdominal wall repair and breast reconstruction postmastectomy. AlloDerm® Tissue Matrix allows surgeons to restore many types of tissue damaged through injury or disease using the regenerative power of their patients’ own tissue.
Launched in 2008, Strattice™ Reconstructive Tissue Matrix is designed to support tissue regeneration by allowing rapid revascularization, cell repopulation and white cell migration - just as leading surgeons have come to expect from LifeCell. In addition to these highly-valued benefits for challenging hernia repair and breast reconstruction, Strattice™ Tissue Matrix offers ease of use, requires no rehydration, can be stored at room temperature and is available in large sizes.
The SPY Elite® Intraoperative Perfusion Assessment System helps surgeons to intraoperatively assess tissue perfusion in plastic, reconstructive, micro, gastrointestinal, and vascular surgical procedures. At present, clinical judgment is the most common method used for perfusion assessment.
The SPY Elite® System may help reduce complication and improve outcomes by offering fast, accurate, intraoperative assessment of perfusion in flaps and native tissues, providing surgeons with real-time information needed to modify plans before the patient leaves the OR table.
Before use, physicians should review all risk information and essential prescribing information which can be found in the Strattice™ Reconstructive Tissue Matrix and AlloDerm® Regenerative Tissue Matrix Instructions for Use.
For complete safety information and complete instructions for the proper use of the SPY Elite® System, please refer to the SPY Elite® System Operator's Manual and SPY Elite® System Kit Instructions for Use. The SPY Elite® System is intended for use as an adjunctive method of assessing tissue perfusion in plastic, reconstructive, micro, gastrointestinal, and vascular surgical procedures. The SPY Elite® System is to be used under the direction of a physician.